Position in VTRS
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$14,127,379
-$2,261,427 QoQ
Shares Held
1,045,698
-20.6% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026KBC Group NV holds $69,833,201 across 25 Drug Manufacturers - Specialty & Generic names. VTRS ranks #2 (20.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
344,903 | $40,770,982 | |
| 2 | VTRS |
Viatris Inc
This page
|
1,045,698 | $14,127,379 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
8,878 | $5,264,475 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
75,831 | $2,311,328 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
17,011 | $2,241,028 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
91,785 | $2,196,415 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
55,414 | $1,669,069 | |
| 8 | ALKS |
Alkermes plc.
|
5,106 | $180,548 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,127,379 | 1,045,698 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $16,388,806 | 1,316,370 | Shares | Defined | 2026-01-26 | |
| 2025-09-30 | $13,204,511 | 1,333,789 | Shares | Defined | 2026-01-20 | |
| 2025-06-30 | $12,197,076 | 1,365,854 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $15,971,056 | 1,833,646 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $25,724,961 | 2,066,262 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $12,082,619 | 1,040,708 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $20,325,877 | 1,912,124 | Shares | Defined | 2024-07-17 | |
| 2024-03-31 | $18,049,052 | 1,511,646 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $3,595,635 | 332,007 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,287,077 | 333,375 | Shares | Defined | 2024-02-15 | |
| 2023-06-30 | $5,620,365 | 563,163 | Shares | Defined | 2024-02-15 | |
| 2023-03-31 | $3,243,334 | 337,145 | Shares | Defined | 2024-02-14 | |
| 2022-12-31 | $3,159,260 | 283,851 | Shares | Defined | 2024-02-14 | |
| 2022-09-30 | $2,001,807 | 234,954 | Shares | Defined | 2024-02-15 | |
| 2022-06-30 | $1,837,547 | 175,506 | Shares | Defined | 2024-02-14 | |
| 2022-03-31 | $1,884,002 | 173,162 | Shares | Defined | 2024-02-14 | |
| 2021-12-31 | $2,342,881 | 173,162 | Shares | Defined | 2024-02-14 | |
| 2021-09-30 | $3,862,861 | 285,082 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $4,091,770 | 286,338 | Shares | Defined | 2022-02-15 | |
| 2021-03-31 | $3,819,831 | 273,431 | Shares | Defined | 2022-02-14 | |
| 2020-12-31 | $4,916,869 | 262,373 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||